Ina Valeria Zurlo

8PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.

Carlo Signorelli, Michele Basso, Maria Alessandra Calegari

|Jun 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.

Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone

|Dec 27, 2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.

Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone

|Nov 27, 2024
A Retrospective Analysis of Real-Life Management of Colorectal Cancer Lung-Limited Metastases Treated with Surgery: Outcomes and Prognostic Factors.

Ina Valeria Zurlo, Maria Alessandra Calegari, Maria Teresa Congedo

|Dec 23, 2023
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.

Sara Stumpo, Maria Giovanna Formelli, Irene Persano

|Nov 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study.

Stefano Granieri, Christian Cotsoglou, Alessandro Bonomi

Pageof 2

Frequent Collaborators

3 joint publications

Alessandro Passardi

3 joint publications

Fiorenza Santamaria

3 joint publications

Alessandro Bittoni

3 joint publications

Giulia Arrivi